On October 8, 2019 Varian (NYSE: VAR) reported that it will showcase the company’s interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla (Press release, Varian Medical Systems, OCT 8, 2019, View Source [SID1234540106]). The Varian interventional oncology portfolio encompasses cryo and microwave ablation systems, as well as embolization microspheres.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Varian is deeply committed to the ongoing development of innovative treatment solutions for clinicians offering ablation and embolization services to patients," said David Chen, vice president, Interventional Oncology Solutions, Varian. "These solutions are an important pillar of patient care and together with our clinical partners we are moving closer to creating a world without fear of cancer."

The Varian solutions on display at the Clinical Interventional Oncology event include:

Cryocare SL System and family of CryoProbes designed to deliver high-performance cryoablation technology for a number of malignant and benign conditions
MicroThermX microwave ablation systems
Portfolio of microsphere products for treating arteriovenous malformations and hypervascular tumors
Embozene Microspheres
Oncozene Microspheres
Velocity 4.0 with RapidSphere, a module for Y90 Selective Internal Radiation Therapy (SIRT) dosimetry analysis
WHERE: Booths # 300 & 302, CIO Symposium, Miami, Fla.

WHEN: Friday, October 11, 2019 through Sunday, October 13, 2019